GENMAB A/S's ticker is GMAB and the CUSIP is 372303206. A total of 194 filers reported holding GENMAB A/S in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $3,870 | -12.0% | 154 | +4.8% | 0.00% | -50.0% |
Q1 2024 | $4,397 | -14.0% | 147 | +1.4% | 0.00% | 0.0% |
Q3 2023 | $5,114 | +102180.0% | 145 | +2.8% | 0.00% | 0.0% |
Q2 2023 | $5 | 0.0% | 141 | -2.8% | 0.00% | 0.0% |
Q1 2023 | $5 | -16.7% | 145 | +1.4% | 0.00% | -33.3% |
Q4 2022 | $6 | -99.9% | 143 | -39.1% | 0.00% | -25.0% |
Q3 2022 | $8,000 | +14.3% | 235 | +4.4% | 0.00% | +33.3% |
Q2 2022 | $7,000 | -12.5% | 225 | +1.4% | 0.00% | 0.0% |
Q1 2022 | $8,000 | -11.1% | 222 | +2.3% | 0.00% | 0.0% |
Q4 2021 | $9,000 | -10.0% | 217 | -2.3% | 0.00% | -25.0% |
Q3 2021 | $10,000 | 0.0% | 222 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $10,000 | +42.9% | 222 | +3.3% | 0.00% | +33.3% |
Q1 2021 | $7,000 | -22.2% | 215 | -0.9% | 0.00% | -40.0% |
Q4 2020 | $9,000 | +12.5% | 217 | -0.9% | 0.01% | +25.0% |
Q3 2020 | $8,000 | – | 219 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 214,848 | $6,980,000 | 2.38% |
Cutter & CO Brokerage, Inc. | 119,956 | $3,897,000 | 1.33% |
Hardman Johnston Global Advisors LLC | 933,449 | $30,328,000 | 1.29% |
Connective Portfolio Management, LLC | 18,000 | $585,000 | 1.00% |
Capricorn Fund Managers Ltd | 148,411 | $4,822,000 | 0.88% |
TORRAY INVESTMENT PARTNERS LLC | 131,708 | $4,279,000 | 0.82% |
First Light Asset Management, LLC | 160,885 | $5,227,000 | 0.61% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 1,857 | $57,189,000 | 0.60% |
Yorktown Management & Research Co Inc | 10,100 | $328,000 | 0.42% |
Integrated Investment Consultants, LLC | 18,550 | $602,000 | 0.22% |